Key result
Myocardial revascularization using the right gastroepiploic artery achieved an early mortality of 1.7%, a 92% early patency rate, and a 2- and 4-year actuarial survival rate of 96.7%.
Population
400 patients undergoing myocardial revascularization using the right gastroepiploic artery to bypass the…
Design
Cohort
Follow-up
up to 4 years
Authors
Loading...
May support right gastroepiploic artery use in select CABG; leaves open superiority versus standard conduits in RCTs.
Cohort (n=400)
Myocardial revascularization using the right gastroepiploic artery is associated with low operative risk, high early patency, and satisfactory midterm survival and functional results.
Jegaden et al. (1995) conducted a cohort in Coronary artery disease (n=400). Myocardial revascularization using the right gastroepiploic artery was evaluated on Early mortality. Myocardial revascularization using the right gastroepiploic artery achieved an early mortality of 1.7%, a 92% early patency rate, and a 2- and 4-year actuarial survival rate of 96.7%.
Synapse has enriched one closely related paper. Consider it for comparative context: